准备论文最后一稿(preparing the final manuscript) 论文初稿完成以后,必须对其内容及格式进行反复的推敲和修改,以达到“投稿须知”所提出的一切要求。尤其是投给期刊的稿件一定要达到期刊所要求的编辑格式,否则不但不能被接受发表,甚至于根本不予考虑。因为绝大多数有经验的编辑都认为:不认真准备的稿件绝不是高水平科学研究成果的良好载体(A poorly prepared manuscript is,almost without fail,the carrier vehicle of poor science. Day AR.)。所以,如果希望论文被发表,在准备投给期刊的稿件时必须做到打字整洁、无错、符合期刊格式、含有期刊要求的所有材料。 准备论文最后一稿一般分三步,首先是再次阅读拟投期刊的“投稿须知”,然后用“投稿须知”中提供的“稿件对照检查表”(manuscript checklist, author's checklist)与自己的论文一一核对,最后根据期刊要求打字,完成最后一稿。
*文题和所有作者的姓名 *稿件适宜的栏目 *为什么此论文适合于在该刊而不是其它刊物上发表*关于重复或部分发表或已投它刊的说明 *不能转让版权的说明(如美国联邦政府雇员) *建议审稿人及因存在竞争关系而不宜做审稿人的名单 *通信作者(corresponding author)的姓名、详细地址、电话和传真号码、e-mail 地址 *能否付出版费(版面费、彩图费)的说明(如果该刊收取版面费和彩图费) *希望核校校样或稿件若不接收退回原稿的要求(有的期刊在“投稿须知”中约定,除非作者在投稿信中提出要求,否则原稿不退还给作者) 投稿信举例: Dear Dr.: Enclosed are three copies of a manuscript by Rose N .Dipaola,Donna A.Gallo,and Tom N.Roberts titled“Hepatitis C Virus Infection in Long-Term Transfusion Patients”.It is submitted to be considered for publication as a“Original Article" in your journal.This paper is~*Neither the entire paper nor any part of its content has been published or has been accepted elsewhere .It is not being submitted to any other journal. We believe the paper may be of particular interest to the readers of your journal because the study it reports stated the HCV infection rate among long-term transfusion patients is higher than that of the general population and of short-term transfusion patients. Correspondence and phone calls about the paper should be directed to Rose N.Dipaola at the following address, phone and fax number,and e-mail address:
Rose N .Dipaola,MD
Institute of Internal Medicine Cleveland Clinic Foundation 9500 Euclid Ave. Cleveland,OH44195,USA Tel:1-216-444-5360 Fax:1-216-444-9580 E-mail:dipao@cesmtp .ccf. Org Thanks very much for your attention to our paper. Sincerely yours, Rose N.Dipaola